Low-carb diet may reverse age-related brain deterioration, study finds
Researchers say brain pathways begin to erode in late 40s, but can be repaired through dietary changes
research
Another Alzheimer’s Vaccine Moves Closer to Human Trials
With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving. The latest study was tested on mice genetically programmed to get Alzheimer’s disease and was successful in removing beta-amyloid plaque and tau protein linked to Alzheimer’s disease in the animals.
Harvard Unveils MRI Study Proving Meditation Literally Rebuilds The Brain’s Gray Matter In 8 Weeks
Test subjects taking part in an 8-week program of mindfulness meditation showed results that astonished even the most experienced neuroscientists at Harvard University. The study was led by a Harvard-affiliated team of researchers based at Massachusetts General Hospital, and the team’s MRI scans documented for the very first time in medical history how meditation produced massive changes inside the brain’s gray matter.
Novel dementia vaccine on track for human trials within two years
A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”
Experts review evidence yoga is good for the brain
Scientists have known for decades that aerobic exercise strengthens the brain and contributes to the growth of new neurons, but few studies have examined how yoga affects the brain. A review of the science finds evidence that yoga enhances many of the same brain structures and functions that benefit from aerobic exercise.
The Newest Directions in Alzheimer’s Research: A Conversation with Dr. Carol Colton
Now the sixth-leading cause of death in the United States (fifth in North Carolina) and the most expensive disease (it costs roughly $341,000 for the health needs of someone from diagnosis to death), what do we know?
Israeli team uses silicon chip to deliver Alzheimer’s-busting protein to brain
In Technion, Bar-Ilan trials, nanochip ferries ‘neural growth factor’ — which combats neurodegenerative diseases — and releases it where needed, overcoming blood-brain barrier
Blood Test For Alzheimer’s Disease Shows 100 Percent Accuracy In Preclinical Studies
Recently, the Alzheimer’s Drug Discovery Foundation gave researchers a $3.5 million award for promising early detection Alzheimer’s tests.
Update on FINGER Study
The World Wide FINGERS (WW-FINGERS) is an interdisciplinary network to share experiences, harmonise data, and plan joint international initiatives for the prevention of cognitive impairment or dementia